These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3923825)

  • 21. Sequence of the full-length immunoglobulin kappa-chain of mouse myeloma MPC 11.
    Smith GP
    Biochem J; 1978 May; 171(2):337-47. PubMed ID: 418775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of intracellular immunoglobulin in extramedullary myeloma.
    Halliday D; Davey FR; Call F; Marucci AA
    Arch Pathol Lab Med; 1977 Oct; 101(10):522-5. PubMed ID: 410387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 24. [Myelomatous G-kappa immunoglobulin with antistreptolysin O activity].
    Tobelem G; Krulik M; Mougeot-Martin M; Audebert AA; Debray J
    Nouv Presse Med; 1976 Nov; 5(38):2515-8. PubMed ID: 824622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diverse hemostatic abnormalities in a patient with biclonal multiple myeloma].
    Komiya I; Ito T; Ogata K; Yamada T; Dan KZ; Kuriya S; Nomura T
    Rinsho Ketsueki; 1990 Jan; 31(1):62-5. PubMed ID: 2107347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
    Panzer S; Thaler E
    Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An unusual case of myeloma. Non-secretory IgD-kappa myeloma with de-differentiation of kappa myeloma evolving from solitary plasmocytoma.
    Nelis GF
    Acta Med Scand; 1982; 211(1-2):141-4. PubMed ID: 6803520
    [No Abstract]   [Full Text] [Related]  

  • 29. IgM anticoagulant with acquired abnormalities in factor VIII.
    Andes WA
    Thromb Res; 1982 Sep; 27(6):703-12. PubMed ID: 6817451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired heparin-like anticoagulation process in a patient with multiple myeloma: a case report and literature review.
    Shen H; Wu C; Chen L; Zhang R
    Transl Cancer Res; 2020 Nov; 9(11):7366-7371. PubMed ID: 35117336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [IgD/kappa myeloma].
    Golenkov AK; German GP; Zlatkina AR; Chernokhvostova EV; Cheredeev AN
    Ter Arkh; 1984; 56(11):129-31. PubMed ID: 6441298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of nonsecreting and nonproducing light chain multiple myeloma.
    Sommer I; Knobel B; Meytes D; Seidel L
    Acta Haematol; 1985; 73(3):173-5. PubMed ID: 3929534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of the serum of a patient affected by myeloma with diffuse muscular hypertrophy on the growth of human muscle cells in vitro].
    Delaporte C; Drouin F; Ract AR; Varet B; Fardeau M
    Rev Neurol (Paris); 1985; 141(2):109-19. PubMed ID: 3923591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.
    Khoory MS; Nesheim ME; Bowie EJ; Mann KG
    J Clin Invest; 1980 Mar; 65(3):666-74. PubMed ID: 6444419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IgM myeloma].
    Assaf ME; Pizzolato MA; De María HE; Gasparini S; Burucua JE
    Sangre (Barc); 1983; 28(5):642-7. PubMed ID: 6420914
    [No Abstract]   [Full Text] [Related]  

  • 36. Shared idiotypic determinants among three electrophoretic components in the IgG-K immunoglobulins from a single individual.
    Krueger RG; Knowlton DR; Fair DS
    Mol Immunol; 1980 Mar; 17(3):345-56. PubMed ID: 6160386
    [No Abstract]   [Full Text] [Related]  

  • 37. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use.
    Harrison RL; Alperin JB; Kumar D
    Arch Pathol Lab Med; 1987 Aug; 111(8):719-22. PubMed ID: 3115223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical importance of paraprotein of the type kappa and lambda in Bence-Jones myeloma].
    Iavorskiĭ LI; Andreeva NE; Antipova LG; Riauzova LN
    Probl Gematol Pereliv Krovi; 1979 Jun; 24(6):3-9. PubMed ID: 111238
    [No Abstract]   [Full Text] [Related]  

  • 40. [Case of IgD kappa multiple myeloma].
    Przybyłowski J; Bartelik S; Slefarska H; Siedlecki J
    Przegl Lek; 1983; 40(8):643-5. PubMed ID: 6420847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.